Monday, 30 April 2007 “The sanctioning of countries for using legitimate and important flexibilities in the TRIPS agreement brings shame to all U.S. citizens who are increasingly seen in Thailand and elsewhere as bullies and hypocrites.” The following is the… Continue Reading
Monday, 30 April 2007 “The sanctioning of countries for using legitimate and important flexibilities in the TRIPS agreement brings shame to all U.S. citizens who are increasingly seen in Thailand and elsewhere as bullies and hypocrites.” The following is the… Continue Reading
12 February 2007
Knowledge Ecology International (KEI) is a non-governmental organization that searches for better outcomes, including new solutions, to the management of knowledge resources.
Original page: http://www.cptech.org/ip/birdflu/ustr-birdflu.html 14 October 2005 Honorable Rob Portman United States Trade Representative 600 17th Street, N.W. Washington, DC 20508 Dear Ambassador Portman: We are writing to ask that the United States government address a mistake in trade policy that… Continue Reading
This is a letter, dated July 22, 2004, by six consumer groups, asking Robert Zoellick and other members of the Bush Administration, to change US trade policy, so that research and development, rather than intellectual property rights, were the focus.… Continue Reading
Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading
30 April 1997 USTR REPORT ON SPECIAL 301 ANNUAL REVIEW FACT SHEET “SPECIAL 301” ON INTELLECTUAL PROPERTY RIGHTS ACTIONS TAKEN Acting United States Trade Representative Charlene Barshefsky today announced the Administration’s decision with respect to this year’s review under the… Continue Reading
On 14 May 2024, the Pharmaceutical Accountability Foundation (PAF) had their first hearing in their case against Abbvie at the Amsterdam District Court. The case concerns Abbvie’s pricing practices for its blockbuster drug Humira (adalimumab), one of the world’s best-selling… Continue Reading
On Tuesday, 28 May 2024, Knowledge Ecology International (KEI) delivered this constituency statement on behalf of KEI, Health Action International, Oxfam, World Blind Union, and the World Council of Churches on the following topic: Intergovernmental Negotiating Body to draft and… Continue Reading